Malignant Mesothelioma - Global Strategic Business Report

Global Malignant Mesothelioma Market to Reach $874.7 Million by 2030

The global market for Malignant Mesothelioma estimated at US$540.7 Million in the year 2022, is projected to reach a revised size of US$874.7 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Premetrexed & Combination, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$468.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cisplatin & Combination segment is readjusted to a revised 6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $162.7 Million, While China is Forecast to Grow at 5.7% CAGR

The Malignant Mesothelioma market in the U.S. is estimated at US$162.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$150.5 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Select Competitors (Total 43 Featured) -

• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Concordia International Corporation
• Corden Pharma International GmbH
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Fresenius Kabi AG
• Kyowa Hakko Kirin Co., Ltd.
• Merck & Co., Inc.
• MolMed S.p.A.
• Mylan NV
• Nichi-Iko Pharmaceutical Co., Ltd.
• Novartis International AG
• Ono Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• Polaris Pharmaceuticals, Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year